Cobalt to Chromium Ratio Is Not a Key Marker for ALTR in Metal on Metal Hips
The diagnosis of adverse local tissue reaction (ALTR) after metal-on-metal total hip arthroplasty (MoMTHA) presents a significant challenge. No single biomarker is specific for ALTR. The purpose of this study was to determine if the ratio of cobalt to chromium ions is useful for diagnosing ALTR in MoMTHA. In 89 bearing-related revision THAs, preoperative cobalt and chromium ion levels were compared to an intraoperative soft tissue damage grading scale. The average cobalt to chromium ratio was 2.96 (0-20). There was no correlation between the tissue scale and the cobalt to chromium ratio (R=0.095; P=0.41). Many variables affecting ion production/excretion mitigate the use of the ion ratio. The cobalt to chromium ratio is not a predictive biomarker for ALTR in MoMTHA.
Copyright © 2015. Published by Elsevier Inc.
adverse local tissue reaction; chromium; cobalt; ion levels; metal-on-metal; pseudotumor
Back
Essential cookies keep the site secure and functional. You can choose whether to allow non-essential cookies below.
Necessary
Required for security, navigation, and core site functionality. These always stay on.
Remember choices such as display preferences to improve your experience on return visits.
Help us understand how visitors use the site so we can improve performance and usability.
Support campaign tracking and embedded third-party tools that help us reach the right audience.
